383 related articles for article (PubMed ID: 36729264)
1. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers.
Wang Y; Deng B
Cancer Metastasis Rev; 2023 Sep; 42(3):629-652. PubMed ID: 36729264
[TBL] [Abstract][Full Text] [Related]
2. Molecular Genetics and Targeted Therapy in Hepatocellular Carcinoma.
Marks EI; Yee NS
Curr Cancer Drug Targets; 2016; 16(1):53-70. PubMed ID: 26373716
[TBL] [Abstract][Full Text] [Related]
3. Decoding the Roles of Long Noncoding RNAs in Hepatocellular Carcinoma.
Wong LS; Wong CM
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808647
[TBL] [Abstract][Full Text] [Related]
4. Theranostical nanosystem-mediated identification of an oncogene and highly effective therapy in hepatocellular carcinoma.
Guo Y; Wang J; Zhang L; Shen S; Guo R; Yang Y; Chen W; Wang Y; Chen G; Shuai X
Hepatology; 2016 Apr; 63(4):1240-55. PubMed ID: 26680504
[TBL] [Abstract][Full Text] [Related]
5. The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment.
D'Anzeo M; Faloppi L; Scartozzi M; Giampieri R; Bianconi M; Del Prete M; Silvestris N; Cascinu S
Molecules; 2014 May; 19(5):6393-406. PubMed ID: 24853455
[TBL] [Abstract][Full Text] [Related]
6. Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review).
Zimonjic DB; Popescu NC
Int J Oncol; 2012 Aug; 41(2):393-406. PubMed ID: 22580498
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma.
Kanda M; Sugimoto H; Kodera Y
World J Gastroenterol; 2015 Oct; 21(37):10584-97. PubMed ID: 26457018
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies.
Alqahtani A; Khan Z; Alloghbi A; Said Ahmed TS; Ashraf M; Hammouda DM
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31450841
[TBL] [Abstract][Full Text] [Related]
9. Non-coding RNAs as biomarkers for hepatocellular carcinoma-A systematic review.
Zhao J; Wang Y; Su H; Su L
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101736. PubMed ID: 34146723
[TBL] [Abstract][Full Text] [Related]
10. Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy.
Han LL; Lv Y; Guo H; Ruan ZP; Nan KJ
World J Gastroenterol; 2014 Aug; 20(30):10249-61. PubMed ID: 25132742
[TBL] [Abstract][Full Text] [Related]
11. Molecular Mechanisms and Targets of Therapy for Hepatocellular Carcinoma.
Klungboonkrong V; Das D; McLennan G
J Vasc Interv Radiol; 2017 Jul; 28(7):949-955. PubMed ID: 28416267
[TBL] [Abstract][Full Text] [Related]
12. Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma.
Zhou Y; Liu F; Ma C; Cheng Q
J Clin Lab Anal; 2022 Oct; 36(10):e24673. PubMed ID: 36036748
[TBL] [Abstract][Full Text] [Related]
13. Improvement in the Current Therapies for Hepatocellular Carcinoma Using a Systems Medicine Approach.
Ozcan M; Altay O; Lam S; Turkez H; Aksoy Y; Nielsen J; Uhlen M; Boren J; Mardinoglu A
Adv Biosyst; 2020 Jun; 4(6):e2000030. PubMed ID: 32529800
[TBL] [Abstract][Full Text] [Related]
14. Epigenetics of hepatocellular carcinoma: role of microRNA.
Khare S; Zhang Q; Ibdah JA
World J Gastroenterol; 2013 Sep; 19(33):5439-45. PubMed ID: 24023486
[TBL] [Abstract][Full Text] [Related]
15. Systemic treatment of advanced hepatocellular cancer: new hope on the horizon.
Chang Lee R; Tebbutt N
Expert Rev Anticancer Ther; 2019 Apr; 19(4):343-353. PubMed ID: 30793991
[TBL] [Abstract][Full Text] [Related]
16. Emerging targeted strategies in advanced hepatocellular carcinoma.
Finn RS
Semin Liver Dis; 2013 Feb; 33 Suppl 1():S11-9. PubMed ID: 23457035
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target.
Hung CH; Chiu YC; Chen CH; Hu TH
Biomed Res Int; 2014; 2014():486407. PubMed ID: 24800233
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations in hepatocellular carcinoma: An update.
Niu ZS; Niu XJ; Wang WH
World J Gastroenterol; 2016 Nov; 22(41):9069-9095. PubMed ID: 27895396
[TBL] [Abstract][Full Text] [Related]
19. Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment.
Yegin EG; Oymaci E; Karatay E; Coker A
Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):234-56. PubMed ID: 27298100
[TBL] [Abstract][Full Text] [Related]
20. RNA interference as therapeutics for hepatocellular carcinoma.
Xu C; Lee SA; Chen X
Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):106-15. PubMed ID: 21110827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
